Non-specific tissue proteins and extracellular matrix components

Non-specific tissue proteins and extracellular matrix components is a broad classification used to describe biological entities that provide structural integrity and a biochemical framework for tissues rather than acting as specific signaling receptors or enzymes. The extracellular matrix (ECM) consists of a complex network of macromolecules, including collagen, elastin, and various glycoproteins, which regulate cell adhesion, migration, and differentiation (Frantz et al., 2010, Journal of Cell Science) [1]. Non-specific tissue proteins, including serum albumin and alpha-1-acid glycoprotein, are major determinants of drug distribution, as they bind many therapeutic agents non-selectively, thereby influencing their free concentration and pharmacokinetics (Smith et al., 2010, Pharmacological Reviews) [2]. In pathological states like fibrosis or cancer, the ECM undergoes significant remodeling, contributing to tissue stiffness and providing a niche for tumor progression (Wynn, 2008, Journal of Pathology) [3]. While most drugs interacting with this category do not have a high-affinity molecular lock-and-key mechanism, they may act through physical shielding, ion exchange, or non-specific adsorption to alter the physiological environment (DrugBank Online, 2024) [4]. Consequently, this term is often used in pharmacological databases to categorize agents with diffuse or poorly defined molecular targets, such as topical protectants or certain gastrointestinal agents.

Other names

Extracellular matrixECMTissue proteinsPlasma proteinsStructural proteins

Non-specific physical or chemical interaction with structural proteins or the extracellular environment to provide protection, sequestration, or structural modification.